FDA 483 - Manuel Teixeira Dairy - May 23, 2023

An FDA inspection of Manuel Teixeira Dairy in Modesto, CA, revealed significant issues related to drug use and record-keeping. Observations included the extralabel use of Flunixin Meglumine resulting in residues above established tolerances in a dairy cow intended for human consumption. Additionally, the dairy failed to follow veterinary prescription directions and maintain complete treatment records for their cattle.